GLPBio

SR-9243

Catalog No.: GC13680Purity:>99.50%
inverse agonist of LXR

Products are for research use only. Not for human use. We do not sell to patients.


SR-9243
Cas No.: 1613028-81-1
10mM (in 1mL DMSO)In Stock
$69.00
1
10mgIn Stock
$53.00
1
50mgIn Stock
$151.00
1
200mgIn Stock
$422.00
1

Citations

1 publicationsPublications from researchers using this product

Description

SR9243 is a liver-X-receptor (LXR) inverse agonist that induces LXR-corepressor interaction. It potently reduces cancer cell viability (IC50=15–104 nM) in MTT reduction assays in prostate (PC3 and DU-145), colorectal (SW620 and HT29), and lung (HOP-62 and NCI-H23) cancer cell lines. [1]

LXR (liver X receptor) is a member of the nuclear receptor family of transcription factors. It is an important regulator of glycolysis and lipogenesis enzyme expression.

In SW620 cells, 1 mM SR9243 treatment for 12 hours induces cell death with a robust increase in caspase 3/7 activation. In addition, SR9243 disrupts the Warburg effect, suppresses lipogenesis gene expression and lipid production in cancer cells without effecting normal cells. [1]

In colon tumor xenograft, SR9243 substantially and dose-dependently reduces tumor growth, glycolytic (GCK1, PFK2, PFK1 and LDH) and lipogenic (SCD1, FASN, and SREBP1c) enzyme expression without promoting weight loss. SR9243 also blocks tumor growth without causing immune or hepatic toxicity in vivo. [1]

Reference:
1.  Flaveny CA, Griffett K, El-Gendy Bel-D et al. Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis. Cancer Cell. 2015 Jul 13;28(1):42-56.

Protocol

Cell experiment [1]:

Cell lines

SW620, HT-29, DU-145, PC3, NCI-H23 and HOP-62 cancer cells

Preparation method

This compound is soluble in DMSO. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below - 20 °C for several months.

Reacting condition

100 nM; 96 hrs

Applications

In a variety of cancer cell lines, SR-9243 reduced cancer cell viability, with IC50 values ranging from 15 ~ 104 nM. In addition, SR-9243 induced apoptotic cell death and sensitized cancer cells to chemotherapeutic treatments.

Animal experiment [1]:

Animal models

Athymic mice bearing SW620 colon cancer xenografts

Dosage form

30 or 60 mg/kg; i.p.; q.d.

Applications

In athymic mice bearing SW620 colon cancer xenografts, SR-9243 substantially reduced the growth of colon cancer xenografts in a dose-dependent manner. Meanwhile, SR-9243-treated tumor-bearing mice did not show any weight loss.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Flaveny CA, Griffett K, El-Gendy Bel-D et al. Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis. Cancer Cell. 2015 Jul 13;28(1):42-56.

Product Documents

Purity:>99.50%Appearance:A solid

Chemical Properties

CAS No.
1613028-81-1
SMILES
CC(C=C(C)C=C1C)=C1S(N(CC2=CC=C(C3=CC(C)=CC=C3)C=C2)CCC4=CC=CC(Br)=C4)(=O)=O.O=S=O
Molecular Formula
C31H32BrNO4S2
Molecular Weight
626.62
Solubility
≥ 25.2 mg/mL in DMSO
Storage
Store at -20°C
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for SR-9243

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%